These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19875481)

  • 21. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
    Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
    Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local activation of the IkappaK-NF-kappaB pathway in muscle does not cause insulin resistance.
    Polkinghorne E; Lau Q; Cooney GJ; Kraegen EW; Cleasby ME
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E316-25. PubMed ID: 18029440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of early insulin therapy on nuclear factor kappaB pathway in skeletal muscle of diabetes: experiment with rats].
    Bi Y; Sun WP; Chen X; Cai MY; Liang H; Zhu YH; He XY; Yu QQ; Li M; Weng JP
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3287-92. PubMed ID: 19159557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
    Lappas M; Yee K; Permezel M; Rice GE
    Endocrinology; 2005 Mar; 146(3):1491-7. PubMed ID: 15564333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation between skeletal muscle inhibitor-kappaB kinase/nuclear factor-kappaB pathway activity and insulin sensitivity in nondiabetic twins.
    Friedrichsen M; Ribel-Madsen R; Wojtaszewski J; Grunnet L; Richter EA; Billestrup N; Ploug T; Vaag A; Poulsen P
    J Clin Endocrinol Metab; 2010 Jan; 95(1):414-21. PubMed ID: 19875481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
    Ruan H; Pownall HJ
    Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention?
    Hommelberg PP; Langen RC; Schols AM; Mensink RP; Plat J
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):647-55. PubMed ID: 20842028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.
    Shoelson SE; Lee J; Yuan M
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S49-52. PubMed ID: 14704745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IKK- and NF-κB-mediated functions in carcinogenesis.
    Arkan MC; Greten FR
    Curr Top Microbiol Immunol; 2011; 349():159-69. PubMed ID: 20845109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF-kappaB signaling: a tale of two pathways in skeletal myogenesis.
    Bakkar N; Guttridge DC
    Physiol Rev; 2010 Apr; 90(2):495-511. PubMed ID: 20393192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review.
    Casanova E; Salvadó J; Crescenti A; Gibert-Ramos A
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-death machinery in IKK/NF-kappaB signaling.
    Luo JL; Kamata H; Karin M
    J Clin Immunol; 2005 Nov; 25(6):541-50. PubMed ID: 16380818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutual regulation of metabolic processes and proinflammatory NF-κB signaling.
    Kracht M; Müller-Ladner U; Schmitz ML
    J Allergy Clin Immunol; 2020 Oct; 146(4):694-705. PubMed ID: 32771559
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.